Your browser doesn't support javascript.
loading
Comparative Single-Dose mRNA and ChAdOx1 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2, Including Variants of Concern: Test-Negative Design, British Columbia, Canada.
Skowronski, Danuta M; Setayeshgar, Solmaz; Zou, Macy; Prystajecky, Natalie; Tyson, John R; Sbihi, Hind; Fjell, Chris D; Galanis, Eleni; Naus, Monika; Patrick, David M; El Adam, Shiraz; Ahmed, May A; Kim, Shinhye; Henry, Bonnie; Hoang, Linda M N; Sadarangani, Manish; Jassem, Agatha N; Krajden, Mel.
Afiliação
  • Skowronski DM; Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Setayeshgar S; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Zou M; Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Prystajecky N; Data and Analytics Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Tyson JR; Public Health Laboratory, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Sbihi H; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Fjell CD; Public Health Laboratory, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Galanis E; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Naus M; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Patrick DM; Data and Analytics Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • El Adam S; Public Health Laboratory, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Ahmed MA; Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Kim S; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Henry B; Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Hoang LMN; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Sadarangani M; Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
  • Jassem AN; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
  • Krajden M; Communicable Diseases and Immunization Services, BC Centre for Disease Control, Vancouver, British Columbia, Canada.
J Infect Dis ; 226(1): 485-496, 2022 08 12.
Article em En | MEDLINE | ID: mdl-35084500
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Adult / Aged / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Limite: Adult / Aged / Humans / Middle aged País/Região como assunto: America do norte Idioma: En Revista: J Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Canadá País de publicação: Estados Unidos